Dutari M Tablet 0.2 mg (Dutasteride)

Adult dose

The recommended dose of this medicine is 1 tablet (0.2mg) once daily. To avoid irritation of the oropharyngeal mucosa, swallow this medicine whole without chewing or splitting it. This medicine may be taken with or without food. No dose adjustment is necessary in patients with renal impairment. Since no data are available on the administration of this medicine to patients with hepatic impairment, the recommended dose in these patients has not been established.

This medication can be absorbed through the skin, so women who are pregnant or may become pregnant should not touch or handle this medication. Women should take particular care when handling broken or crushed pieces of this medication, and children should also be kept from touching any broken pieces. This medication should not be administered to women, children under 18 years of age, or patients with hypersensitivity to this medication or its ingredients. Adult men planning to conceive should use this medication cautiously under a doctor's supervision, as it may impact fertility. Patients with significant residual urine or severe urinary stream reduction symptoms should exercise caution when using this medication and closely monitor for the occurrence of urinary retention. Patients with impaired liver function should be administered this medication carefully, as its metabolism may be affected. Patients taking strong CYP3A4 inhibitors for prolonged periods should be aware that blood levels of this medication may be increased. During treatment, erectile dysfunction, decreased libido, and ejaculatory disorders may occur; if symptoms persist, consult a physician. This medication can lower serum PSA levels, so PSA levels before and after taking the medication should be compared for prostate cancer screening. Regular risk assessments for prostate cancer and PSA tests while on this medication are recommended. Do not donate blood for at least six months during or after taking this medication, as this is to prevent transmission of the medication to pregnant women. Safety and efficacy of this medication have not been established in children under 18 years of age, so it should not be used in this population. This medication is known not to affect the ability to drive or operate machinery, but caution may be needed depending on individual reactions. There is no specific antidote for overdosing; if overdose symptoms are suspected, seek immediate medical attention for appropriate treatment. Store this medication out of reach of children and keep it in its original container to prevent misuse and maintain quality.

• erectile dysfunction
• ejaculatory dysfunction
• sexual dysfunction
• increased ALT
• increased AST
• increased blood lactate dehydrogenase
• decreased seminal fluid volume
• epididymitis
• mental disorders
• decreased libido

This medication should be stored in a tightly closed container that is well-ventilated and kept at room temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the effectiveness of the medication.

Appearance

Yellow rectangular film-coated tablet

Package unit

30 tablets/box [(10 tablets/PTP x 3)]